thanks... don't like AF but here's his take.. https://www.thestreet.com/story/14043007/1/astrazeneca-takes-parp-inhibitor-fight-to-rival-tesaro-with-strong-ovarian-cancer-study-results.html just curious about AZN's early detection tweets... where does that lead to?